Skip to content
Politically.com Search all
Menu

2025 · 1st Quarter (Jan 1 - Mar 31)

OMEROS CORPORATION

Filed by AVENUE SOLUTIONS.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-09-23 06:26:10 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Termination
Posted
Jul 21, 2025
Income
$80,000.00
Expenses
Not reported
Filing UUID
5f07830b-1d71-4ecd-b89b-51aa5a582955
Termination date
Mar 31, 2025

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

Issues related to the FDA and treatment for rare disease

HCR · Health Issues

Issues related to the expiration/extension of Priority Review Vouchers (PRVs) for rare disease; S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4)

Literal federal measure citations: S. 891, H.R. 1968

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.